MEASUREMENT OF SERUM TUMOR-MARKER CA-125 IN OVARIAN CARCINOMAS - COMPARATIVE-STUDY BETWEEN ENZYME-IMMUNOASSAY (EIA) AND IMMUNORADIOMETRIC ASSAY (IRA)

Google Scholar
  • 1 March 1988
    • journal article
    • research article
    • Vol. 36  (3) , 225-229
Abstract
CA 125, tumor marker newly appeared, is used in ovarian carciomas. Its determination in serum is an important progress, not only in diagnosis but above all at the time of monitoring of clinical course during the treatment. The determination is possible with immunoradiometric assay (IRA) or enzyme immunoassay (EIA). The comparative study show a good correlation between these two methods. Both give comparable results. The choice for either method depends on equipment of laboratory.